Literature DB >> 8518597

The problem with cholesterol.

M G Dunnigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8518597      PMCID： PMC1677777          DOI： 10.1136/bmj.306.6889.1355

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Should there be a moratorium on the use of cholesterol lowering drugs?

Authors:  G Davey Smith; J Pekkanen
Journal:  BMJ       Date:  1992-02-15

2.  Mortality experience in cholesterol-reduction trials.

Authors:  M F Muldoon; S B Manuck; K A Matthews
Journal:  N Engl J Med       Date:  1991-03-28       Impact factor: 91.245

3.  Cholesterol and total mortality: need for larger trials.

Authors:  R Collins; A Keech; R Peto; P Sleight; J Kjekshus; L Wilhelmsen; S MacMahon; J Shaw; J Simes; E Braunwald
Journal:  BMJ       Date:  1992-06-27

Review 4.  Might treatment of hypercholesterolaemia increase non-cardiac mortality?

Authors:  M F Oliver
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

5.  Treating hypercholesterolemia. How should practicing physicians interpret the published data for patients?

Authors:  A S Brett
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

6.  Possibly disappointing results of treatment with gemfibrozil.

Authors:  T B Newman
Journal:  N Engl J Med       Date:  1993-01-14       Impact factor: 91.245

7.  Consensus conferences as drug promotion.

Authors:  T A Sheldon; G D Smith
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

8.  Report of the Conference on Low Blood Cholesterol: Mortality Associations.

Authors:  D Jacobs; H Blackburn; M Higgins; D Reed; H Iso; G McMillan; J Neaton; J Nelson; J Potter; B Rifkind
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

9.  Cholesterol lowering and mortality: the importance of considering initial level of risk.

Authors:  G D Smith; F Song; T A Sheldon
Journal:  BMJ       Date:  1993-05-22
  9 in total
  6 in total

1.  Comparison of appropriateness of cholesterol testing in general practice with the recommendations of national guidelines: an audit of patient records in 20 general practices.

Authors:  T van der Weijden; A Dansen; B J Schouten; J A Knottnerus; R P Grol
Journal:  Qual Health Care       Date:  1996-12

2.  Ischaemic heart disease and cholesterol. Cholesterol reduction effective in established disease...

Authors:  P N Durrington
Journal:  BMJ       Date:  1994-04-16

3.  Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study.

Authors:  S A Grover; I Lowensteyn; K L Esrey; Y Steinert; L Joseph; M Abrahamowicz
Journal:  BMJ       Date:  1995-04-15

4.  Liver transplantation for homozygous familial hypercholesterolaemia.

Authors:  S P Revell; G Noble-Jamieson; P Johnston; A Rasmussen; N Jamieson; N D Barnes
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

5.  Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration.

Authors:  H C Bucher; M Weinbacher; K Gyr
Journal:  BMJ       Date:  1994-09-24

6.  Cholesterol confusion in primary prevention of coronary artery disease.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1993-11       Impact factor: 3.727
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.